1. Home
  2. LUCD vs LSE Comparison

LUCD vs LSE Comparison

Compare LUCD & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • LSE
  • Stock Information
  • Founded
  • LUCD 2018
  • LSE 2007
  • Country
  • LUCD United States
  • LSE China
  • Employees
  • LUCD 70
  • LSE N/A
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LSE Metal Fabrications
  • Sector
  • LUCD Health Care
  • LSE Industrials
  • Exchange
  • LUCD Nasdaq
  • LSE Nasdaq
  • Market Cap
  • LUCD 108.0M
  • LSE 91.8M
  • IPO Year
  • LUCD 2021
  • LSE 2024
  • Fundamental
  • Price
  • LUCD $1.07
  • LSE $5.49
  • Analyst Decision
  • LUCD Strong Buy
  • LSE
  • Analyst Count
  • LUCD 5
  • LSE 0
  • Target Price
  • LUCD $3.65
  • LSE N/A
  • AVG Volume (30 Days)
  • LUCD 1.6M
  • LSE 4.0K
  • Earning Date
  • LUCD 11-12-2025
  • LSE 05-08-2013
  • Dividend Yield
  • LUCD N/A
  • LSE N/A
  • EPS Growth
  • LUCD N/A
  • LSE N/A
  • EPS
  • LUCD N/A
  • LSE 0.52
  • Revenue
  • LUCD $4,360,000.00
  • LSE $69,073,374.00
  • Revenue This Year
  • LUCD $22.80
  • LSE N/A
  • Revenue Next Year
  • LUCD $221.19
  • LSE N/A
  • P/E Ratio
  • LUCD N/A
  • LSE $10.68
  • Revenue Growth
  • LUCD 14.74
  • LSE N/A
  • 52 Week Low
  • LUCD $0.73
  • LSE $3.76
  • 52 Week High
  • LUCD $1.80
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 50.26
  • LSE 52.45
  • Support Level
  • LUCD N/A
  • LSE $5.29
  • Resistance Level
  • LUCD $1.09
  • LSE $5.58
  • Average True Range (ATR)
  • LUCD 0.09
  • LSE 0.22
  • MACD
  • LUCD -0.06
  • LSE 0.02
  • Stochastic Oscillator
  • LUCD 69.53
  • LSE 60.08

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: